Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Trials & Approvals

Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Zai Lab Raises $261 Million; Plans China NDA Filing for Ripretinib in Mid-2020

Roche's Kadcyla, a Breast Cancer Treatment, Is First ADC Approved in China

Ascletis Approved to Start China Trial of PD-L1 in HBV Patients

TenNor Receives Orphan Drug Designation in the US for Biofilm Infection Candidate

Roche Approved to Market Alecensa, an ALK-Blocker, for NSCLC in China

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China